Comparative analysis of plasma metabolomics markers in patients with major depressive disorder and healthy controls
Introduction Mood disorders, including depression, are diseases associated with an increased risk of several metabolic alterations. Metabolomics studies have proved their potential for detecting novel biomarkers of psychiatric diseases. Objectives To analyze the plasma metabolite profiling of pati...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Cambridge University Press
2022-06-01
|
Series: | European Psychiatry |
Subjects: | |
Online Access: | https://www.cambridge.org/core/product/identifier/S0924933822008355/type/journal_article |